Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

ImmunityBio (IBRX) Leases: 2019-2025

Historic Leases for ImmunityBio (IBRX) over the last 7 years, with Sep 2025 value amounting to $33.2 million.

  • ImmunityBio's Leases fell 5.01% to $33.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.2 million, marking a year-over-year decrease of 5.01%. This contributed to the annual value of $33.4 million for FY2024, which is 8.70% down from last year.
  • As of Q3 2025, ImmunityBio's Leases stood at $33.2 million, which was down 4.40% from $34.7 million recorded in Q2 2025.
  • ImmunityBio's 5-year Leases high stood at $48.1 million for Q2 2022, and its period low was $18.4 million during Q1 2021.
  • Its 3-year average for Leases is $36.0 million, with a median of $34.9 million in 2024.
  • As far as peak fluctuations go, ImmunityBio's Leases soared by 171.26% in 2021, and later dropped by 22.87% in 2023.
  • Quarterly analysis of 5 years shows ImmunityBio's Leases stood at $36.3 million in 2021, then grew by 26.12% to $45.8 million in 2022, then fell by 20.19% to $36.5 million in 2023, then dropped by 8.70% to $33.4 million in 2024, then fell by 5.01% to $33.2 million in 2025.
  • Its Leases stands at $33.2 million for Q3 2025, versus $34.7 million for Q2 2025 and $31.8 million for Q1 2025.